Vaddi Krishna Insider Trades

Insider Trading History

Track insider trading activity for Vaddi Krishna. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Prelude Therapeutics
Prelude Therapeutics PRLD
CEO
Holding Value $3.41M 837,000 shares
Last Trade
Feb 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.93M 837,000 shares
$2.30
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
CEO
Holding Value $8.16M 1,999,296 shares
Last Trade
Mar 25, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$466k 675,000 shares
$0.69
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
CEO
Holding Value $5.4M 1,324,296 shares
Last Trade
Mar 21, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$11k 15,000 shares
$0.73
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
CEO
Holding Value $5.34M 1,309,296 shares
Last Trade
Mar 20, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.95k 5,416 shares
$0.73
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
CEO
Holding Value $5.32M 1,303,880 shares
Last Trade
Mar 17, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.83k 9,106 shares
$0.75
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
CEO
Holding Value $5.28M 1,294,774 shares
Last Trade
Mar 14, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$22.5k 29,999 shares
$0.75
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
CEO
Holding Value $5.16M 1,264,775 shares
Last Trade
Mar 13, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$36k 50,000 shares
$0.72
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
CEO
Holding Value $4.96M 1,214,775 shares
Last Trade
Mar 12, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$33.7k 47,500 shares
$0.71
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
CEO
Holding Value $2.02M 496,000 shares
Last Trade
Feb 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$551k 496,000 shares
$1.11
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
CEO
Holding Value $582k 142,553 shares
Last Trade
Dec 31, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.05k 5,000 shares
$1.21
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
CEO
Holding Value $561k 137,553 shares
Last Trade
Dec 30, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$12k 10,000 shares
$1.20
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
CEO
Holding Value $520k 127,553 shares
Last Trade
Dec 19, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.13k 6,888 shares
$0.89
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
CEO
Holding Value $4.76M 1,167,275 shares
Last Trade
Dec 18, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$93k 100,000 shares
$0.93
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
CEO
Holding Value $1.73M 425,000 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.95M 425,000 shares
$4.59
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
CEO
Holding Value $4.35M 1,067,275 shares
Last Trade
May 25, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.78k 900 shares
$5.31
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
CEO
Holding Value $4.35M 1,066,375 shares
Last Trade
May 24, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.01k 1,000 shares
$5.01
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
CEO
Holding Value $4.35M 1,065,375 shares
Last Trade
May 23, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$66.7k 11,856 shares
$5.63
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
CEO
Holding Value $1.35M 330,000 shares
Last Trade
Feb 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.38M 330,000 shares
$7.20
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Director, CEO
Holding Value $492k 120,665 shares
Last Trade
Dec 20, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$98.4k 19,188 shares
$5.13
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
CEO
Holding Value $1.34M 327,900 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.47M 327,900 shares
$10.58
$4.08

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up